Jeonju-si, South Korea

Han-na Kim

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Han-na Kim

Introduction

Han-na Kim, located in Jeonju-si, South Korea, is an accomplished inventor with a focus on improving biotechnological applications. With a patent to his name, he has made significant strides in the field of RNA technology, which plays a crucial role in modern medicine and therapeutic applications.

Latest Patents

Han-na Kim holds a patent for a "High-efficiency nanoparticle-type double-helical oligo-RNA structure and method for preparing same." This innovative patent provides a double-stranded oligo RNA structure designed to enhance stability and cell delivery efficiency. By covalently binding a polymer compound to the double-stranded oligo RNA, Han-na Kim's invention ensures the oligo RNA remains functional while also improving its stability and permeability to cell membranes. This advancement allows for effective delivery into the cells, even at low concentrations, making it a promising tool for the treatment of cancer and infectious diseases, as well as a novel delivery system for double-stranded oligo RNA.

Career Highlights

Currently, Han-na Kim is affiliated with Bioneer Corporation, where he contributes to groundbreaking research and development initiatives. His work focuses on leveraging RNA technology to enhance medical treatments and improve health outcomes.

Collaborations

Throughout his career, Han-na Kim has collaborated with talented coworkers, including Jeiwook Chae and Boram Han. These partnerships reflect a dynamic environment driven by innovation and scientific exploration, allowing them to tackle complex challenges in biotechnology together.

Conclusion

Han-na Kim's contributions to the field of biotechnology, particularly with his innovative RNA structural patents, highlight his commitment to improving healthcare solutions. His work at Bioneer Corporation, paired with strong collaborations, positions him as a prominent figure in the advancement of biotechnological applications aimed at treating serious medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…